Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03742024 · ClinicalTrials.gov registry record
Study of Pediatric Migraine: The Pediatric Migraine Registry
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 201
- Enrollment target
NCT03742024: Completed study, sponsored by Duke University.
NCT03742024 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 201 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03742024 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 201 participants
- Enrollment target
Study Summary
This is a multi-center registry that will prospectively collect regulatory compliant data from children and adolescents with migraine. This study will enroll approximately 200 participants from approximately 20 sites and will examine migraine symptoms, therapeutics used, and biomarkers associated with migraine.
Primary Outcome
Number of days per month participant experiences migraine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2021-02-08 |
What the finished NCT03742024 record still lists
NCT03742024 is an observational study that tracks outcomes without assigning an intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03742024 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03742024 about?
NCT03742024 is a clinical study titled "Study of Pediatric Migraine: The Pediatric Migraine Registry". This is a multi-center registry that will prospectively collect regulatory compliant data from children and adolescents with migraine. This study will enroll approximately 200 participants from approximately 20 sites and will examine migraine symptoms, therapeutics used, and biomarkers associated wi...
What is the current status of trial NCT03742024?
This trial is currently completed. The enrollment target is 201 participants. The study started on 2018-12-05. Estimated completion is 2021-02-08.
Who is sponsoring clinical trial NCT03742024?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI